[Advance in research on microdeletion/microduplications at Xp22.3]

Area of Science:

• Genetics
• Reproductive Medicine
• Genomic Medicine

Background:

• Microdeletion and microduplication syndromes at chromosome band Xp22.3 are frequently identified through advanced prenatal diagnostic techniques.
• The increasing prevalence and limited understanding of these genetic variations pose challenges for accurate clinical genetic counseling.
• Array-comparative genome hybridization (aCGH) and BACs-on-Beads (BoBs) technologies have significantly improved the detection rates of these conditions.

Purpose of the Study:

• To provide a comprehensive review of the current research on microdeletion and microduplication disorders at Xp22.3.
• To consolidate information on the epidemiology, pathogenesis, clinical manifestations, and prenatal diagnostic approaches for Xp22.3 genetic variations.
• To enhance the knowledge base for improved genetic counseling and management of affected individuals.

Main Methods:

• Literature review of recent research on Xp22.3 microdeletions and microduplications.
• Analysis of studies focusing on epidemiological data, molecular mechanisms, clinical phenotypes, and diagnostic strategies.
• Synthesis of findings from studies utilizing technologies like aCGH and BoBs.

Main Results:

• Xp22.3 microdeletions/microduplications are being detected more frequently in prenatal settings.
• There is a growing body of research detailing the genetic causes and clinical outcomes associated with these chromosomal abnormalities.
• Current diagnostic methods offer improved resolution for identifying these specific genomic alterations.

Conclusions:

• A better understanding of Xp22.3 microdeletions/microduplications is crucial for effective genetic counseling.
• Continued research is needed to fully elucidate the genotype-phenotype correlations and long-term implications.
• Advances in prenatal diagnosis facilitate earlier identification and management planning for these genetic disorders.